Mark S. Litwin, Sheldon Greenfield, Eric P. Elkin, Deborah P. Lubeck, Jeanette M. Broering and Sherrie H. Kaplan Assessment of prognosis with the total illness burden index for prostate cancer Cancer 109
Version of Record online: 12 MAR 2007 | DOI: 10.1002/cncr.22615
Men who had the highest scores on the Total Illness Burden Index for Prostate Cancer (TIBI-CaP), a patient-reported measure of comorbidity, were 13 times more likely to die of causes other than prostate cancer over the subsequent 3.5 years after initial treatment than men who had the lowest scores. Because the TIBI-CaP identified patients at high risk for nonprostate cancer mortality, it may aid physicians and patients in making appropriate treatment decisions.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field